Effects of corticoid agonists and antagonists on apical Na+ permeability of toad urinary bladder

H Garty1, K Peterson-Yantorno, C Asher

  • 1Department of Membrane Research and Biophysics, Weizmann Institute of Science, Rehovot, Israel.

Insights

Aldosterone

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Physiology

Background:

  • Aldosterone is a key hormone regulating sodium transport in the kidney.
  • Glucocorticoid receptors are also present in the kidney and can influence sodium transport.
  • The precise roles of mineralocorticoid and glucocorticoid receptors in regulating sodium permeability are not fully understood.

Purpose of the Study:

  • To investigate the roles of mineralocorticoid and glucocorticoid receptors in regulating apical sodium permeability in toad bladder.
  • To correlate steroid effects with receptor occupancy.
  • To explore potential cross-talk between mineralocorticoid and glucocorticoid signaling pathways.

Main Methods:

  • Experiments were conducted using whole toad bladders, isolated plasma membrane vesicles, and RNA-injected Xenopus oocytes.
  • Steroids used included RU-28362 (glucocorticoid agonist), RU-38486 (glucocorticoid antagonist), and RU-26752 (mineralocorticoid antagonist).
  • Receptor occupancy was measured and correlated with functional effects on sodium permeability.

Main Results:

  • Glucocorticoid antagonist RU-38486 partially inhibited aldosterone's effect on sodium permeability, suggesting a role for glucocorticoid receptors.
  • Unexpectedly, co-application of aldosterone and RU-38486 in oocytes resulted in channel activity exceeding the sum of individual effects.
  • Full occupancy of both receptor types by agonists/antagonists yielded only partial effects, indicating a complex response.

Conclusions:

  • At least one-third of aldosterone's sodium-transporting action in toad bladder is mediated via the glucocorticoid receptor.
  • The observed effects suggest a complex interplay between mineralocorticoid and glucocorticoid receptors, not fully explained by simple receptor occupancy.
  • Further research is needed to elucidate the mechanisms underlying these complex interactions.

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...